No, the FDA Didn’t Reject MDMA Therapy Because of Big Pharma—It Was Because of Shoddy Science
The evidence points less to wariness of psychedelics and more to too little experience with clinical trial standards…
The evidence points less to wariness of psychedelics and more to too little experience with clinical trial standards…
Read More
About Author
